Last reviewed · How we verify
Severe, acute hypotension in adult patients
Approved treatments
- Levophed · Pfizer Inc.
Peripheral vasoconstrictor via alpha-adrenergic action and cardiac inotropic stimulator with coronary vasodilation via beta-adrenergic action.
Clinical guidelines
- FDA label — 1L
Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with severe, acute hypotension.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Severe, acute hypotension in adult patients patent landscape — cliff calendar, originator estates, attackable patents
- Severe, acute hypotension in adult patients treatment landscape brief
- Severe, acute hypotension in adult patients treatment updates RSS
Frequently asked questions about Severe, acute hypotension in adult patients
What drugs treat Severe, acute hypotension in adult patients?
Tracked treatments include Levophed.
What is the treatment for Severe, acute hypotension in adult patients?
Standard treatment for Severe, acute hypotension in adult patients includes Levophed. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Severe, acute hypotension in adult patients?
FDA label publishes guidelines for Severe, acute hypotension in adult patients. 1 guideline references tracked.
Related
- Treatment landscape: Severe, acute hypotension in adult patients patent cliff · Severe, acute hypotension in adult patients CI report
- Treatment: Levophed · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing